/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

N

Nils Homann

Fraunhofer Project Centre Wolfsburg(DE)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

189

Papers

10.0K

Citations

38

h-index

84

i10-index

Nils Homann is an academic researcher from Fraunhofer Project Centre Wolfsburg. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Esophageal Cancer Research and Treatment & Gastrointestinal Tumor Research and Treatment. The author has an h-index of 38, co-authored 161 publications.

Research Topics

Gastric Cancer Management and Outcomes Esophageal Cancer Research and Treatment Gastrointestinal Tumor Research and Treatment Colorectal Cancer Treatments and Studies Alcohol Consumption and Health Effects

Papers by this author

works

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

2019 · The Lancet · 2,440 citations

https://doi.org/10.1016/s0140-6736(18)32557-1

Salah‐Eddin Al‐Batran Nils Homann Claudia Pauligk Thorsten Oliver Goetze

Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial

2023 · Journal of Clinical Oncology · 182 citations

https://doi.org/10.1200/jco.23.00975

Sylvie Lorenzen Thorsten Oliver Götze Peter Thuss‐Patience Matthias Biebl

Trastuzumab in combination with 5‐fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2‐positive locally advanced esophagogastric adenocarcinoma: A phase <scp>II</scp> trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group

2021 · International Journal of Cancer · 97 citations

https://doi.org/10.1002/ijc.33696

Ralf‐Dieter Hofheinz S. Hegewisch-Becker Volker Kunzmann Peter Thuss‐Patience

FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2–Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group

2022 · Journal of Clinical Oncology · 89 citations

https://doi.org/10.1200/jco.22.00380

Ralf‐Dieter Hofheinz Kirsten Merx Georg Martin Haag Christoph Springfeld

Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM

2023 · International Journal of Cancer · 21 citations

https://doi.org/10.1002/ijc.34495

Thorsten Oliver Goetze Ralf‐Dieter Hofheinz Timo Gaiser Harald Schmalenberg

Premedication with orally administered lorazepam in adults undergoing ERCP: a randomized double-blind study

2007 · Gastrointestinal Endoscopy · 13 citations

https://doi.org/10.1016/j.gie.2007.01.036

Günther Weitz Nils Homann Dorothea Clara von Jagow Peter Wellhöner

Research topics

topics

Gastric Cancer Management and Outcomes

Esophageal Cancer Research and Treatment

Gastrointestinal Tumor Research and Treatment

Colorectal Cancer Treatments and Studies

Alcohol Consumption and Health Effects

Chat about Author

Papers

Chat

Click to start Chat